Back to all news
October 8, 2024
News,
Product news

The smart choice for quantitative faecal immunochemical testing – QuikRead go iFOBT

QuikRead go iFOBT is a user-friendly and reliable test for detecting faecal haemoglobin.

QuikRead go iFOBT is a point-of-care test that features an intuitive procedure on the QuikRead go Instrument. The test is ideal for routine physical exams, symptomatic patients (e.g. lower abdominal symptoms), and for colorectal cancer screening.

QuikRead go iFOBT is easy to implement as a part of your healthcare routine:

  • Effective triage tool: assists in timely assessment and decision-making for referrals to colonoscopy1.
  • Accurate results: instrument-read quantitative results with possibility to adjust cut-off values (from 10-200 µg/g in faeces or 50-1000 ng/ml in test solution).
  • Flexibility: use of nationally recommended cut-off values which might be different for colorectal cancer screening and symptomatic patients2.
  • Personalized analysis: quantitative results can be weighed against each patient’s age, gender, or potential risk factors1,3,4.
  • Convenient: handy sampling tube for easy sample storage.

Benefits of the QuikRead go Instrument:

  • Fully automated measurement: ensures accuracy and efficiency.
  • Portable and battery-powered: ideal for various healthcare settings.
  • Connectivity: bi-directional connectivity to most HIS/LIS systems.

Learn more about the QuikRead go iFOBT test and QuikRead go Instrument.


References

  1. Navarro M, Hijos G, Ramirez T, et al. Fecal hemoglobin concentration, a good predictor of risk of advanced colorectal neoplasia in symptomatic and asymptomatic Patients. Front Med 2019;6:31.
  2. National Institute for Health and Care Excellence (NICE). Quantitative faecal immunochemical testing to guide colorectal cancer pathway referral in primary care 2023. https://www.nice.org.uk/guidance/dg56
  3. Burnett-Hartman AN, Lee JK, Demb J, et al. An Update on the Epidemiology, Molecular Characterization, Diagnosis, and Screening Strategies for Early-Onset Colorectal Cancer. Gastroenterology 2021; 160:1041-1049.
  4. Fraser C, Rubeca T, Stefano R, et al. Faecal haemoglobin concentrations vary with sex and age, but data are not transferable across geography for colorectal cancer screening. Clin. Chem. Lab. Med 2014; 52 (8).


Share